CSIR Central

A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia

IR@IICB: CSIR-Indian Institute of Chemical Biology, Kolkata

View Archive Info
 
 
Field Value
 
Title A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia
 
Creator Sinha, D
Mandal, Chitra
Bhattacharyya, DK
 
Subject Infectious Diseases and Immunology
 
Description Although childhood acute lymphoblastic leukemia (ALL) is highly responsive to chemotherapy, patients in remission may harbor residual leukemic blasts, the cause of disease persistence and resurgence.1 Improved assays are therefore needed to evaluate individual chemotherapeutic response and predict impending relapse. Employing a 9-O acetyl sialic acid binding lectin, ATNH, we have identified two 9-O acetylated sialoglycoconjugates (9-OAcSGs), as novel biomarkers on leukemic blasts of newly diagnosed/untreated ALL patients2 of both B and/or T lineages and assessed their differential expression at different phases of therapy.3 Presently, we describe a noninvasive, blood-based lymphoproliferation assay to evaluate the clinical status of B lineage ALL patients (HLA-DR+,CD19+, n = 16) followed up longitudinally for 3 years. ALL patients, who received treatment as per the UKALLVIII protocol, were bled at different phases of therapy. Peripheral blood mononuclear cells were isolated and cultured with ATNH (0.05–12 mg) for 96 h followed by an 18 h pulse with 3H-TdR. Radioactivity incorporated, in individual samples, was plotted against ATNH dose and the dose corresponding to maximal incorporation of radioactivity was designated as its ‘maximal lymphoproliferative dose’ (MLD). The MLD was employed to evaluate the percentage recovery of individual patients.
 
Publisher Nature Publishing Group
 
Date 1999
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/709/1/LEUKEMIA_13(_2)_309%2D312;1999[80].pdf
Sinha, D and Mandal, Chitra and Bhattacharyya, DK (1999) A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukemia, 13 (2). pp. 309-312.
 
Relation htp://dx.doi.org/10.1038/sj.leu.2401312
http://www.eprints.iicb.res.in/709/